These Directives amend the Medical Devices Directives (AIMDD, 90/385/EEC & MDD, 93/42/EEC).
Directive relating to the incorporation into the MDD (93/42/EEC) of substances which, if used separately, may be considered to be medicinal product constituents or a medicinal products derived from human blood or human plasma (‘human blood derivative’) and which are liable to act upon the human body with action ancillary to that of the device.
- Directive 2000/70/EC - OJ L 313, 13/12/2000
Directive amending MDD (93/42/EEC) excluding human blood, blood products, plasma or blood cells of human origin or to devices which incorporate at the time of placing on the market such blood products, plasma or cells, other than devices that incorporate, as an integral part, a substance which, if used separately, may be considered to be a medicinal product constituent or a medicinal product derived from human blood or human plasma (‘human blood derivative’) and which are liable to act upon the human body with action ancillary to that of the device.
- Directive 2001/104/EC - OJ L 6/50, 10/01/2002
Directive revising the Active Implantable Medical Devices Directive (AIMDD, 90/385/EEC) and Medical Devices Directive (MDD, 93/42/EEC), published in the Official Journal of the European Communities (OJ) on 21 September 2007. Member states have until December 21 2008 to adopt and publish the laws implementing the revising Directive, and until 21 March 2010 to apply them. Consolidated versions of the revised directives have been published by the European Commission.
- Directive 2007/47/EC - OJ L 247/21, 21/09/2007